×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
SYRE – spyre therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
SYRE
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/16
12:47 pm
syre
Spyre Therapeutics (SYRE) had its "buy" rating reaffirmed by BTIG Research. They now have a $70.00 price target on the stock.
Low
Report
Spyre Therapeutics (SYRE) had its "buy" rating reaffirmed by BTIG Research. They now have a $70.00 price target on the stock.
3/16
08:23 am
syre
Spyre Announces Acceleration of Expected Topline Readout of SKYWAY Rheumatoid Arthritis Sub-study to Q3 2026 [Yahoo! Finance]
High
Report
Spyre Announces Acceleration of Expected Topline Readout of SKYWAY Rheumatoid Arthritis Sub-study to Q3 2026 [Yahoo! Finance]
3/16
08:00 am
syre
Spyre Announces Acceleration of Expected Topline Readout of SKYWAY Rheumatoid Arthritis Sub-study to Q3 2026
Medium
Report
Spyre Announces Acceleration of Expected Topline Readout of SKYWAY Rheumatoid Arthritis Sub-study to Q3 2026
3/11
01:41 am
syre
Spyre Therapeutics, Inc. (SYRE) Presents at Leerink Global Healthcare Conference 2026 Transcript [Seeking Alpha]
Low
Report
Spyre Therapeutics, Inc. (SYRE) Presents at Leerink Global Healthcare Conference 2026 Transcript [Seeking Alpha]
3/6
04:05 pm
syre
Spyre Therapeutics Announces Grants of Inducement Awards
Low
Report
Spyre Therapeutics Announces Grants of Inducement Awards
2/24
04:25 pm
syre
Spyre Therapeutics to Participate in Upcoming March Investor Conferences [Yahoo! Finance]
Low
Report
Spyre Therapeutics to Participate in Upcoming March Investor Conferences [Yahoo! Finance]
2/24
04:05 pm
syre
Spyre Therapeutics to Participate in Upcoming March Investor Conferences
Low
Report
Spyre Therapeutics to Participate in Upcoming March Investor Conferences
2/24
06:48 am
syre
Spyre Therapeutics (NASDAQ:SYRE) was upgraded by analysts at Leerink Partners to a "strong-buy" rating.
Low
Report
Spyre Therapeutics (NASDAQ:SYRE) was upgraded by analysts at Leerink Partners to a "strong-buy" rating.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/5
06:04 am
syre
Form EFFECT Spyre Therapeutics, Inc.
Low
Report
Form EFFECT Spyre Therapeutics, Inc.
3/3
09:33 pm
syre
Form 4 Spyre Therapeutics, Inc. For: Mar 03 Filed by: Burrows Scott L
Low
Report
Form 4 Spyre Therapeutics, Inc. For: Mar 03 Filed by: Burrows Scott L
3/3
09:32 pm
syre
Form 4 Spyre Therapeutics, Inc. For: Mar 02 Filed by: Turtle Cameron
Low
Report
Form 4 Spyre Therapeutics, Inc. For: Mar 02 Filed by: Turtle Cameron
3/3
04:45 pm
syre
Form 144 Spyre Therapeutics, Inc. Filed by: Burrows Scott L
Low
Report
Form 144 Spyre Therapeutics, Inc. Filed by: Burrows Scott L
3/2
04:32 pm
syre
Form 144 Spyre Therapeutics, Inc. Filed by: Turtle Cameron
Medium
Report
Form 144 Spyre Therapeutics, Inc. Filed by: Turtle Cameron
3/2
06:09 am
syre
Form EFFECT Spyre Therapeutics, Inc.
Low
Report
Form EFFECT Spyre Therapeutics, Inc.
2/27
04:02 pm
syre
Form POS AM Spyre Therapeutics, Inc.
Low
Report
Form POS AM Spyre Therapeutics, Inc.
2/19
04:34 pm
syre
Form S-3 Spyre Therapeutics, Inc.
High
Report
Form S-3 Spyre Therapeutics, Inc.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: